COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,162 Articles (22,703 medRxiv, 8,459 bioRxiv)

Most recent first Previous |  Page 506: Articles 5051-5060  | Next

Structure-based discovery of inhibitors of the SARS-CoV-2 Nsp14 N7-methyltransferase
Singh, I., Li, F., Fink, E., Chau, I., Li, A., Rodriguez-Hernandez, A., Glenn, I., Zapatero-Belinchon, F. J., Rodriguez, M., Devkota, K., Deng, Z., White, K., Wan, X., Tolmachova, N. A., Moroz, Y. S., Kaniskan, H. U., Ott, M., Gastia-Sastre, A., Jin, J., Fujimori, D. G., Irwin, J. J., Vedadi, M., Shoichet, B. K.
10.1101/2023.01.12.523677 — Posted: 2023-01-13
Pathogenesis of Breakthrough Infections with SARS-CoV-2 Variants in Syrian Hamsters
Plunkard, J., Mulka, K., Zhou, R., Tarwater, P., Zhong, W., Lowman, M., Wong, A., Pekosz, A., Villano, J.
10.1101/2023.01.12.523876 — Posted: 2023-01-13
A Scoping Review of Factors used to Explain Disparities in COVID-19 Vaccination Intentions and Uptake among People of Color: United States, December 1, 2020-April 30, 2021
Wilson, R. F., Kota, K. K., Sheats, K., Luna-Pinto, C., Owens, C., Harrison, D., Razi, S.
10.1101/2023.01.12.23284499 — Posted: 2023-01-13
Effectiveness of Paxlovid - a review
Paltra, S., Conrad, T.
10.1101/2023.01.13.23284506 — Posted: 2023-01-13
Diagnostic performance of lateral flow immunoassays for COVID-19 antibodies in Peruvian population
Calderon-Flores, R. A., Caceres-Cardenas, G., Ali, K., De Vos, M., Emperador, D., Caceres, T., Eca, A., Villa, L., Albertini, A., Sacks, J. A., Ugarte-Gil, C.
10.1101/2023.01.13.23284518 — Posted: 2023-01-13
Monitoring and responding to emerging infectious diseases in a university setting: A case study using COVID-19
Soda, K. J., Chen, X., Feinn, R., Hill, D.
10.1101/2023.01.13.23284515 — Posted: 2023-01-13
The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 Spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifest.
Iles, R. K.
10.1101/2023.01.13.23284524 — Posted: 2023-01-13
Data-driven Targeting of COVID-19 Vaccination Programs: An Analysis of the Evidence on Impact, Implementation, Ethics and Equity
McLaren, Z. M.
10.1101/2023.01.12.23284481 — Posted: 2023-01-13
Anthracyclines inhibit SARS-CoV-2 infection
Wang, Z., Pan, Q., Ma, L., Zhao, J., McIntosh, F., Liu, Z., Ding, S., Lin, R., Shan, C., Finzi, A., Liang, C.
10.1101/2023.01.10.523518 — Posted: 2023-01-13
Safety and Efficacy of Oral administrated Cepharathine in Non-hospitalized, asymptomatic or mild COVID-19 patients: A Double-blind, Randomized, Placebo-controlled Trial
Wei, J., Pan, S., Liu, S., Qian, B., Shen, Z., Zhang, Y., Bian, Y., ABuduaini, A., Dong, F., Zhang, X., Li, J., Yu, Y., Zhang, W., Wang, J., Zhai, W., Song, Q., Zheng, Y., Li, L., Pan, W., Yu, L., Zhang, Q., Zhang, N., Zheng, J., Yao, C., Li, H.
10.1101/2023.01.11.23284098 — Posted: 2023-01-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).